0001634632-16-000002.txt : 20160318 0001634632-16-000002.hdr.sgml : 20160318 20160318171027 ACCESSION NUMBER: 0001634632-16-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20160318 DATE AS OF CHANGE: 20160318 EFFECTIVENESS DATE: 20160318 FILER: COMPANY DATA: COMPANY CONFORMED NAME: venBio Global Strategic Fund II L.P. CENTRAL INDEX KEY: 0001634632 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-236281 FILM NUMBER: 161516862 BUSINESS ADDRESS: STREET 1: 1700 OWENS STREET STREET 2: SUITE 595 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-522-0100 MAIL ADDRESS: STREET 1: 1700 OWENS STREET STREET 2: SUITE 595 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 D/A 1 primary_doc.xml X0707 D/A LIVE 0001634632 venBio Global Strategic Fund II L.P. 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA CALIFORNIA 94158 415-800-0800 CAYMAN ISLANDS None None Limited Partnership true 2015 N/A venBio Global Strategic GP II, L.P. c/o venBio Partners LLC 1700 Owens Street, Suite 595 San Francisco CA CALIFORNIA 94158 Director General Partner of the Issuer N/A venBio Global Strategic GP II, Ltd. c/o venBio Partners LLC 1700 Owens Street, Suite 595 San Francisco CA CALIFORNIA 94158 Director General Partner of the Issuer's General Partner Robert Adelman c/o venBio Partners LLC 1700 Owens Street, Suite 595 San Francisco CA CALIFORNIA 94158 Director Director of the General Partner of the Issuer's General Partner Corey Goodman c/o venBio Partners LLC 1700 Owens Street, Suite 595 San Francisco CA CALIFORNIA 94158 Director Director of the General Partner of the Issuer's General Partner Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.7 true 0001634632-15-000001 2015-03-25 false true false 0 303000000 288000000 15000000 false 22 0 0 0 true An affiliate of the general partner (or its designee) will receive an annual fee for management services equal to a percentage of each investor's subscription to the Issuer, as specified in the Issuer's partnership agreement. false venBio Global Strategic Fund II L.P. /s/ Scott Epstein Scott Epstein Chief Financial Officer & Chief Compliance Officer 2016-03-18